OmniAb, Inc. (OABIW) stock
OABIWNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31Also trades as OABI
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 10/309% above fair value
$0.41−0.01 (-2.38%)
Close on Oct 30, 2026Market cap $742.95MP/E –Yield –
OmniAb cash
Cash and short-term investments held at the end of each period.
OmniAb's cash was $64.21M at Sep 30, 2026. For fiscal 2025 it was $54.03M, down 9.9% from the year before. The highest annual figure on record is $88.71M in fiscal 2022.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $54.03M | -9.9% |
| FY2024 | Dec 31, 2024 | $59.99M | -31.5% |
| FY2023 | Dec 31, 2023 | $87.54M | -1.3% |
| FY2022 | Dec 31, 2022 | $88.71M | – |
| FY2021 | Dec 31, 2021 | $0 | – |
| FY2020 | Dec 31, 2020 | $0 | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $64.21M | +6.9% |
| Q2 FY2026 | Jun 30, 2026 | $52.00M | +23.3% |
| Q1 FY2026 | Mar 31, 2026 | $49.07M | +11.1% |
| Q4 FY2025 | Dec 31, 2025 | $54.03M | -9.9% |
| Q3 FY2025 | Sep 30, 2025 | $60.06M | +0.2% |
| Q2 FY2025 | Jun 30, 2025 | $42.18M | -27.0% |
| Q1 FY2025 | Mar 31, 2025 | $44.16M | -36.5% |
| Q4 FY2024 | Dec 31, 2024 | $59.99M | -31.5% |
| Q3 FY2024 | Sep 30, 2024 | $59.94M | -38.3% |
| Q2 FY2024 | Jun 30, 2024 | $57.79M | -44.3% |
| Q1 FY2024 | Mar 31, 2024 | $69.57M | -39.0% |
| Q4 FY2023 | Dec 31, 2023 | $87.54M | -1.3% |
| Q3 FY2023 | Sep 30, 2023 | $97.19M | – |
| Q2 FY2023 | Jun 30, 2023 | $103.71M | – |
| Q1 FY2023 | Mar 31, 2023 | $114.01M | – |
| Q4 FY2022 | Dec 31, 2022 | $88.71M | – |
| Q3 FY2022 | Sep 30, 2022 | $0 | -100.0% |
| Q2 FY2022 | Jun 30, 2022 | $0 | -100.0% |
| Q1 FY2022 | Mar 31, 2022 | $0 | – |
| Q4 FY2021 | Dec 31, 2021 | $0 | – |
| Q3 FY2021 | Sep 30, 2021 | $362.20K | – |
| Q2 FY2021 | Jun 30, 2021 | $36.15K | – |
| Q1 FY2021 | Mar 31, 2021 | $0 | – |
| Q4 FY2020 | Dec 31, 2020 | $0 | – |